Of the 310 patients with NSCLC, driver mutations were detected as follows: KRAS, 116 (41%); EGFR, 51 (18%); ALK, 9 (3%), with additional driver alterations detected as per Table 1. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.